🇺🇸 FDA
Patent

US 10179767

Substituted benzamides and methods of use thereof

granted A61PA61P1/00A61P1/02

Quick answer

US patent 10179767 (Substituted benzamides and methods of use thereof) held by Xenon Pharmaceuticals Inc. expires Mon Jan 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Xenon Pharmaceuticals Inc.
Grant date
Tue Jan 15 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61P, A61P1/00, A61P1/02, A61P1/04, A61P11/00